Document is current
Any future updates will be listed below
-
Authors
Kehoe, Lindsay http://orcid.org/0000-0001-5434-443X
Locke, Trevan
McClellan, Mark
Landray, Martin
Hernandez, Adrian
Okun, Sally
- License Information
-
More Information
Article History
Received: 12 March 2024
Accepted: 4 September 2024
First Online: 16 September 2024
Declarations
:
: Not applicable.
: Not applicable.
: The author(s) declared the following potential conflicts of interest with respect to the research, authorship, and/or publication of this article: Dr. McClellan is an independent director on the boards of Johnson & Johnson, Cigna, Alignment Healthcare, and PrognomIQ; co-chairs the Guiding Committee for the Health Care Payment Learning and Action Network; and receives fees for serving as an advisor for Arsenal Capital Partners, Blackstone Life Sciences, and MITRE. Dr. Hernandez receives research funding from American Heart Association, American Regent, Amgen, AstraZeneca, Bayer, Boehringer Ingelheim, Lilly, National Institute of Health, Novartis, Novo Nordisk, Merck and Patient Centered Outcomes Research Institute, Verily; consulting fees from AstraZeneca, Bayer, Boston Scientific, Bristol Myers Squibb, Cytokinetics, Eidos Therapeutics, GlaxoSmithKline, Intellia Therapeutics, Intercept Pharmaceuticals, Myokardia, Novo Nordisk, Novartis, Prolaio, and TikkunLev Therapeutics. Dr. Landray conducts research supported by institutional grants from Novartis, Boehringer Ingelheim, Regeneron, Sanofi, Moderna, Apollo Therapeutics, Schmidt Futures, Flu Lab, Google Ventures, the U.K. Research & Innovation (Medical Research Council), National Institute for Health Research, Wellcome, and Bill & Melinda Gates Foundation.
